FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

830162004: Zanubrutinib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3880815018 Zanubrutinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3880816017 Zanubrutinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zanubrutinib This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Non-specific protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Zanubrutinib Is a Non-specific protein-tyrosine kinase inhibitor true Inferred relationship Some
Zanubrutinib Is a Piperidine true Inferred relationship Some
Zanubrutinib Is a Enzyme inhibitor false Inferred relationship Some
Zanubrutinib Is a Antineoplastic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing zanubrutinib in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zanubrutinib Inferred relationship Some 1
Product containing zanubrutinib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zanubrutinib Inferred relationship Some 1
Zanubrutinib only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zanubrutinib Inferred relationship Some 1
Product containing only zanubrutinib in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zanubrutinib Inferred relationship Some 1
Product containing precisely zanubrutinib 80 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Zanubrutinib Inferred relationship Some 1
Product containing precisely zanubrutinib 80 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Zanubrutinib Inferred relationship Some 1

This concept is not in any reference sets

Back to Start